Jump to content

Cancer survivor: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
fix
Citation bot (talk | contribs)
m Alter: pages, issue, journal, isbn. Add: type, url, pages, citeseerx, chapter-url, year, issue, volume, pmc, pmid, title. Converted bare reference to cite template. Removed parameters. Formatted dashes. You can use this bot yourself. Report bugs here. | Headbomb
Line 18: Line 18:
Some people reject the term ''survivor'' as being a narrow conceptualization of highly variable human experiences. Alternatives include '''alivers''' and '''thrivers''', which put emphasis on living as well as possible, despite limitations and disability.<ref name=Sulik /><!-- Page 321 --> A third term, the '''diers''', is used by some terminally ill patients who reject the claim that dying is part of survivorship or should be covered up with inappropriately optimistic language.<ref name=Sulik /><!-- Page 346 -->
Some people reject the term ''survivor'' as being a narrow conceptualization of highly variable human experiences. Alternatives include '''alivers''' and '''thrivers''', which put emphasis on living as well as possible, despite limitations and disability.<ref name=Sulik /><!-- Page 321 --> A third term, the '''diers''', is used by some terminally ill patients who reject the claim that dying is part of survivorship or should be covered up with inappropriately optimistic language.<ref name=Sulik /><!-- Page 346 -->


The term '''previvor''' has been used to describe [[Genetic carrier|unaffected carriers]]. Unaffected carriers, or previvors, are those who have not diagnosed with [[cancer]], but who know that they are likely to develop cancer due to certain [[genetic mutation]]s that form a known [[cancer syndrome]]. They have a sur'''vived''' the '''pre'''disposition, or higher risk, of cancer.<ref name=NYTimes>{{cite news |author=Amy Harmon |title=The DNA Age, Cancer Free at Age 33, but Weighing a Mastectomy |url=https://www.nytimes.com/2007/09/16/health/16gene.html |work=The New York Times |date=16 September 2007 |accessdate=2007-09-16}}</ref><ref>http://facingourrisk.org/pre-vivors_and_survivors/cancer_pre-vivors.html</ref> As such, this is the first generation in human history who, armed with information about a predisposition to a cancer after opting into [[DNA]] testing, can make informed choices prior to cancer diagnosis. The typical previvor has tested positive for a [[BRCA mutation]] and learned that she is at high risk for developing [[breast cancer]] and [[ovarian cancer]], and is attempting to manage that risk through a combination of increased surveillance through mammograms, breast MRIs, [[pelvic ultrasound]]s, [[oophorectomy]], [[bilateral mastectomy]], and other medical procedures. There has been much controversy over the term ''previvor'', due to the fact that the name compares these healthy women to people have actually been diagnosed with invasive cancer.
The term '''previvor''' has been used to describe [[Genetic carrier|unaffected carriers]]. Unaffected carriers, or previvors, are those who have not diagnosed with [[cancer]], but who know that they are likely to develop cancer due to certain [[genetic mutation]]s that form a known [[cancer syndrome]]. They have a sur'''vived''' the '''pre'''disposition, or higher risk, of cancer.<ref name=NYTimes>{{cite news |author=Amy Harmon |title=The DNA Age, Cancer Free at Age 33, but Weighing a Mastectomy |url=https://www.nytimes.com/2007/09/16/health/16gene.html |work=The New York Times |date=16 September 2007 |accessdate=2007-09-16}}</ref><ref>{{cite web | url=http://facingourrisk.org/pre-vivors_and_survivors/cancer_pre-vivors.html | title=FORCE &#124; Special Populations : Cancer Previvors}}</ref> As such, this is the first generation in human history who, armed with information about a predisposition to a cancer after opting into [[DNA]] testing, can make informed choices prior to cancer diagnosis. The typical previvor has tested positive for a [[BRCA mutation]] and learned that she is at high risk for developing [[breast cancer]] and [[ovarian cancer]], and is attempting to manage that risk through a combination of increased surveillance through mammograms, breast MRIs, [[pelvic ultrasound]]s, [[oophorectomy]], [[bilateral mastectomy]], and other medical procedures. There has been much controversy over the term ''previvor'', due to the fact that the name compares these healthy women to people have actually been diagnosed with invasive cancer.


==Needs of cancer survivors==
==Needs of cancer survivors==
Line 31: Line 31:


====Fear of cancer recurrence====
====Fear of cancer recurrence====
Patients whose cancer is in remission may still have to cope with the uncertainty that at any time their cancer could return without warning. After the initial treatment has ended, [[anxiety]] is more common among cancer survivors than among other people.<ref name="pmid23759376" /> This anxiety regarding the cancer's return is referred to as fear of cancer recurrence.<ref>{{Cite journal|last=Thewes|first=B.|last2=Lebel|first2=S.|last3=Leclair|first3=C. Seguin|last4=Butow|first4=P.|date=2016-05-01|title=A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors|url=https://link.springer.com/article/10.1007/s00520-015-3025-x|journal=Supportive Care in Cancer|language=en|volume=24|issue=5|pages=2269–2276|doi=10.1007/s00520-015-3025-x|issn=0941-4355|pmc=4805701|pmid=26581900}}</ref> Many patients are anxious that any minor [[symptom]] indicates that the cancer has returned, with as many as 9 in 10 patients fearful that their cancer will recur or spread.<ref name=Sun /> In addition to the appearance of any new aches and pains, common triggers for a fear that the cancer may return include hearing that someone else has been diagnosed with cancer, annual medical exams to determine whether the cancer recurred and news stories about cancer.<ref>{{cite journal
Patients whose cancer is in remission may still have to cope with the uncertainty that at any time their cancer could return without warning. After the initial treatment has ended, [[anxiety]] is more common among cancer survivors than among other people.<ref name="pmid23759376" /> This anxiety regarding the cancer's return is referred to as fear of cancer recurrence.<ref>{{Cite journal|last=Thewes|first=B.|last2=Lebel|first2=S.|last3=Leclair|first3=C. Seguin|last4=Butow|first4=P.|date=2016-05-01|title=A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors|journal=Supportive Care in Cancer|language=en|volume=24|issue=5|pages=2269–2276|doi=10.1007/s00520-015-3025-x|issn=0941-4355|pmc=4805701|pmid=26581900}}</ref> Many patients are anxious that any minor [[symptom]] indicates that the cancer has returned, with as many as 9 in 10 patients fearful that their cancer will recur or spread.<ref name=Sun /> In addition to the appearance of any new aches and pains, common triggers for a fear that the cancer may return include hearing that someone else has been diagnosed with cancer, annual medical exams to determine whether the cancer recurred and news stories about cancer.<ref>{{cite journal
|vauthors=Gill KM, Mishel M, Belyea M |title=Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors
|vauthors=Gill KM, Mishel M, Belyea M |title=Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors
|journal=Oncol Nurs Forum
|journal=Oncol Nurs Forum
Line 39: Line 39:
|date=May 2004
|date=May 2004
|pmid=15146229
|pmid=15146229
|doi=10.1188/04.ONF.633-639 |display-authors=etal}}</ref> This anxiety leads to more medical check ups, which can be measured even after a period of up to ten years.<ref name="Follow">{{cite journal | author = Nicolaije K.A. ''et al.'' | year = | title = Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: A study from the population-based PROFILES registry | url = | journal = Gynecologic Oncology | volume = 129 | issue = 2| pages = 324–331 | doi = 10.1016/j.ygyno.2013.02.018 | pmid = 23435365 | date=May 2013}}</ref> This fear can have a significant impact on individual's lives, resulting in difficulties in their daily life such as work and socialising, and difficulties planning for the future.<ref name="Custers 1202–1208">{{Cite journal|last=Custers|first=José A. E.|last2=Tielen|first2=Ronald|last3=Prins|first3=Judith B.|last4=Wilt|first4=Johannes H. W. de|last5=Gielissen|first5=Marieke F. M.|last6=Graaf|first6=Winette T. A. van der|date=2015-09-14|title=Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?|url=https://dx.doi.org/10.3109/0284186X.2014.1003960|journal=Acta Oncologica|volume=54|issue=8|pages=1202–1208|doi=10.3109/0284186X.2014.1003960|issn=0284-186X|pmid=25734906}}</ref> Overall, fear of cancer recurrence is related to a reduced quality of life in cancer survivors<ref name="Custers 1202–1208"/>
|doi=10.1188/04.ONF.633-639 |display-authors=etal}}</ref> This anxiety leads to more medical check ups, which can be measured even after a period of up to ten years.<ref name="Follow">{{cite journal | author = Nicolaije K.A. ''et al.'' | title = Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: A study from the population-based PROFILES registry | url = | journal = Gynecologic Oncology | volume = 129 | issue = 2| pages = 324–331 | doi = 10.1016/j.ygyno.2013.02.018 | pmid = 23435365 | date=May 2013}}</ref> This fear can have a significant impact on individual's lives, resulting in difficulties in their daily life such as work and socialising, and difficulties planning for the future.<ref name="Custers 1202–1208">{{Cite journal|last=Custers|first=José A. E.|last2=Tielen|first2=Ronald|last3=Prins|first3=Judith B.|last4=Wilt|first4=Johannes H. W. de|last5=Gielissen|first5=Marieke F. M.|last6=Graaf|first6=Winette T. A. van der|date=2015-09-14|title=Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?|journal=Acta Oncologica|volume=54|issue=8|pages=1202–1208|doi=10.3109/0284186X.2014.1003960|issn=0284-186X|pmid=25734906}}</ref> Overall, fear of cancer recurrence is related to a reduced quality of life in cancer survivors<ref name="Custers 1202–1208"/>


While Fear of Cancer Recurrence (FCR) can be adaptive at low levels, high levels of FCR require psychological treatment. At present, there are no psychometrically sound measures of FCR, which makes research into the effectiveness of treatment protocols difficult to interpret.<ref>{{cite journal|last1=Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay,|title=Fear of cancer recurrence: a systematic literature review of self‐report measure|journal=Psycho‐Oncology|date=2012|volume=21|issue=6|pages=571–587|doi=10.1002/pon.2070}}</ref> Treatments that are being investigated include: [[cognitive-behavioural therapy]],<ref>{{cite journal|last1=van de Wal, M. A., Gielissen, M. F., Servaes, P., Knoop, H., Speckens, A. E., & Prins, J. B.|title=Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence.|journal=BMC Psychology|date=2015|volume=3|issue=1|page=12|doi=10.1186/s40359-015-0068-1}}</ref> Meta-cognitive therapy<ref>{{cite journal|last1=Butow, P. N., Bell, M. L., Smith, A. B., Fardell, J. E., Thewes, B., Turner, J., ... & Shih, S.|title=Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence|journal=BMC Cancer|date=2013|volume=13|issue=1|page=201|doi=10.1186/1471-2407-13-201}}</ref> and Cognitive-existential group therapy<ref>{{cite journal|last1=Maheu, C., Lebel, S., Courbasson, C., Lefebvre, M., Singh, M., Bernstein, L. J., ... & Ramanakumar, A. V.|title=Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer|journal=BMC Cancer|date=2016|volume=16|issue=1|page=291|doi=10.1186/s12885-016-2326-x}}</ref> and exercise.<ref>{{Cite journal|last=Brown|first=Justin C.|last2=Damjanov|first2=Nevena|last3=Courneya|first3=Kerry S.|last4=Troxel|first4=Andrea B.|last5=Zemel|first5=Babette S.|last6=Rickels|first6=Michael R.|last7=Ky|first7=Bonnie|last8=Rhim|first8=Andrew D.|last9=Rustgi|first9=Anil K.|title=A Randomized Dose-Response Trial of Aerobic Exercise and Health-Related Quality of Life in Colon Cancer Survivors|url=http://onlinelibrary.wiley.com/doi/10.1002/pon.4655/abstract|journal=Psycho-Oncology|language=en|pages=n/a–n/a|doi=10.1002/pon.4655|issn=1099-1611}}</ref>
While Fear of Cancer Recurrence (FCR) can be adaptive at low levels, high levels of FCR require psychological treatment. At present, there are no psychometrically sound measures of FCR, which makes research into the effectiveness of treatment protocols difficult to interpret.<ref>{{cite journal|last1=Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay,|title=Fear of cancer recurrence: a systematic literature review of self‐report measure|journal=Psycho‐Oncology|date=2012|volume=21|issue=6|pages=571–587|doi=10.1002/pon.2070|pmid=22021099}}</ref> Treatments that are being investigated include: [[cognitive-behavioural therapy]],<ref>{{cite journal|last1=van de Wal, M. A., Gielissen, M. F., Servaes, P., Knoop, H., Speckens, A. E., & Prins, J. B.|title=Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence.|journal=BMC Psychology|date=2015|volume=3|issue=1|page=12|doi=10.1186/s40359-015-0068-1|pmid=25977758|pmc=4431367}}</ref> Meta-cognitive therapy<ref>{{cite journal|last1=Butow, P. N., Bell, M. L., Smith, A. B., Fardell, J. E., Thewes, B., Turner, J., ... & Shih, S.|title=Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence|journal=BMC Cancer|date=2013|volume=13|issue=1|page=201|doi=10.1186/1471-2407-13-201|pmid=23617696|pmc=3652728}}</ref> and Cognitive-existential group therapy<ref>{{cite journal|last1=Maheu, C., Lebel, S., Courbasson, C., Lefebvre, M., Singh, M., Bernstein, L. J., ... & Ramanakumar, A. V.|title=Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer|journal=BMC Cancer|date=2016|volume=16|issue=1|page=291|doi=10.1186/s12885-016-2326-x|pmid=27112319|pmc=4845394}}</ref> and exercise.<ref>{{Cite journal|last=Brown|first=Justin C.|last2=Damjanov|first2=Nevena|last3=Courneya|first3=Kerry S.|last4=Troxel|first4=Andrea B.|last5=Zemel|first5=Babette S.|last6=Rickels|first6=Michael R.|last7=Ky|first7=Bonnie|last8=Rhim|first8=Andrew D.|last9=Rustgi|first9=Anil K.|title=A Randomized Dose-Response Trial of Aerobic Exercise and Health-Related Quality of Life in Colon Cancer Survivors|journal=Psycho-Oncology|volume=27|issue=4|language=en|pages=1221–1228|doi=10.1002/pon.4655|pmid=29388275|pmc=5895514|issn=1099-1611|year=2018}}</ref>


====Survivorship====
====Survivorship====
Line 51: Line 51:
Cancer survivors frequently need medical monitoring, and some treatments for unrelated diseases in the future may be contraindicated. For example, a patient who has had a significant amount of [[radiation therapy]] may not be a good candidate for more radiation treatments in the future. To assist with these needs, "survivor care plans" have been promoted. These are personalized documents that describe the person's diagnosis and treatment in detail, list common known side effects, and specifically outline the steps that the survivor should take in the future, ranging from maintaining a healthy weight to receiving specific medical tests on a stated schedule.<ref name = Plans />
Cancer survivors frequently need medical monitoring, and some treatments for unrelated diseases in the future may be contraindicated. For example, a patient who has had a significant amount of [[radiation therapy]] may not be a good candidate for more radiation treatments in the future. To assist with these needs, "survivor care plans" have been promoted. These are personalized documents that describe the person's diagnosis and treatment in detail, list common known side effects, and specifically outline the steps that the survivor should take in the future, ranging from maintaining a healthy weight to receiving specific medical tests on a stated schedule.<ref name = Plans />


Medical tests to determine whether the cancer has returned commonly provoke fears. Informally, this is called ''scanxiety'', a portmanteau of ''scan'' and ''anxiety''. A desire to avoid feeling this fear can prompt survivors to postpone or refuse tests.<ref>{{Cite book|url=https://books.google.com/books?id=eFqpCwAAQBAJ|title=Social Work in Health Settings: Practice in Context|last=McCoyd|first=Judith L. M.|last2=Kerson|first2=Toba Schwaber|date=2016-03-02|publisher=Routledge|isbn=9781317409113|language=en|chapter=Chapter 9}}</ref><ref>{{Cite journal|last=Feiler|first=Bruce|date=2011-06-13|title=Scanxiety. Fear of a postcancer ritual|url=http://content.time.com/time/specials/packages/article/0,28804,2075133_2075127_2075107,00.html|journal=Time|volume=177|issue=24|pages=56|issn=0040-781X|pmid=21682131}}</ref>
Medical tests to determine whether the cancer has returned commonly provoke fears. Informally, this is called ''scanxiety'', a portmanteau of ''scan'' and ''anxiety''. A desire to avoid feeling this fear can prompt survivors to postpone or refuse tests.<ref>{{Cite book|chapter-url=https://books.google.com/books?id=eFqpCwAAQBAJ|title=Social Work in Health Settings: Practice in Context|last=McCoyd|first=Judith L. M.|last2=Kerson|first2=Toba Schwaber|date=2016-03-02|publisher=Routledge|isbn=9781317409113|language=en|chapter=Chapter 9}}</ref><ref>{{Cite journal|last=Feiler|first=Bruce|date=2011-06-13|title=Scanxiety. Fear of a postcancer ritual|url=http://content.time.com/time/specials/packages/article/0,28804,2075133_2075127_2075107,00.html|journal=Time|volume=177|issue=24|pages=56|issn=0040-781X|pmid=21682131}}</ref>


Survivors of childhood cancer have a [[life expectancy]] up to 28% shorter than people in the general population.<ref name="pmid20368646" /> Therefore, there is a need to closely monitor these patients for much longer than usual. The [[Children's Oncology Group]] recommends that monitoring should include periodic follow up and screening by a clinician familiar with these patients' risks. Improving these patients' [[longevity]] requires recognition and treatment of illnesses associated with late effects in the decades after therapy for childhood cancer. For example, survivors of childhood cancer may have more difficulty than typical with [[breastfeeding]] and require more support to undertake this health-promoting activity.<ref>{{cite journal
Survivors of childhood cancer have a [[life expectancy]] up to 28% shorter than people in the general population.<ref name="pmid20368646" /> Therefore, there is a need to closely monitor these patients for much longer than usual. The [[Children's Oncology Group]] recommends that monitoring should include periodic follow up and screening by a clinician familiar with these patients' risks. Improving these patients' [[longevity]] requires recognition and treatment of illnesses associated with late effects in the decades after therapy for childhood cancer. For example, survivors of childhood cancer may have more difficulty than typical with [[breastfeeding]] and require more support to undertake this health-promoting activity.<ref>{{cite journal
Line 64: Line 64:


==Adolescent and young adult survivors==
==Adolescent and young adult survivors==
Adolescent and young adult (AYA) survivors, often defined as being between the ages of 15 and 39, have seen advancements in technology and modern medicine causing a dramatic increase in the number of AYA survivors. Prior to 1970, being diagnosed with cancer during childhood was considered a universally fatal disease. From 1995 to 2000, however, the 5-year survival rate for children diagnosed with cancer was 80%.<ref>{{cite journal|last=Ries|first=LA|author2=Eisener, MP |author3=Kosary, CL |title=SEER cancer statistics review, 1975-2001|journal=National Cancer Institute|year=2004}}</ref> Significant progress has been built in the last 25 years as there are now approximately 270,000 survivors of pediatric cancer in the U.S., which translates to approximately 1 in every 640 young adults being a survivor of childhood cancer.<ref>{{cite journal|last=Aziz|first=NM |author2=Oeffinger, KC |author3=Brooks, S |author4=Turoff, AJ.|title=Comprehensive long-term follow-up programs for pediatric cancer survivors|journal=Cancer|year=2009|pages=841–848}}</ref><ref>{{cite book|last=Hewitt|first=M|title=Childhood cancer survivorship: Improving care and quality of life|year=2003|publisher=National Academies Press|location=Washington, D.C.|author2=Weisner, SL |author3=Simone, JV }}</ref> However, as studies have shown, as patient needs increase, the likelihood of having an unmet need also increases.<ref>{{cite journal|last=Heinrich|first=RL|author2=Schag, CC |author3=Ganz, PA |title=Living with cancer. The cancer inventory of problem situations.|journal=Journal of Clinical Psychiatry|year=1984|volume=40|pages=972–980|doi=10.1002/1097-4679(198407)40:4<972::aid-jclp2270400417>3.0.co;2-w}}</ref> For the AYA population, 2 out of 3 childhood cancer survivors will develop 1 complication due to the therapy they received and 1 out of 3 will develop serious or life-threatening complications, meaning they will most likely need treatment and follow-up care.<ref>{{cite journal|last=Oeffinger|first=KC|author2=Hudson|title=MM|journal=CA: A Cancer Journal for Clinicians|year=2004|volume=54|pages=208–236|doi=10.3322/canjclin.54.4.208}}</ref> In addition, AYAs may experience greater difficulties adhering to treatment, which may negatively impact future outcomes.<ref>{{Cite journal|last=Robertson|first=Eden|last2=Wakefield|first2=Claire|last3=Marshall|first3=Kate|last4=Sansom-Daly|first4=Ursula|date=2015-07-10|title=Strategies to improve adherence to treatment in adolescents and young adults with cancer: a systematic review|url=https://dx.doi.org/10.2147/COAYA.S85988|journal=Clinical Oncology in Adolescents and Young Adults|language=English|volume= 5|doi=10.2147/coaya.s85988|pages=35}}</ref>
Adolescent and young adult (AYA) survivors, often defined as being between the ages of 15 and 39, have seen advancements in technology and modern medicine causing a dramatic increase in the number of AYA survivors. Prior to 1970, being diagnosed with cancer during childhood was considered a universally fatal disease. From 1995 to 2000, however, the 5-year survival rate for children diagnosed with cancer was 80%.<ref>{{cite journal|last=Ries|first=LA|author2=Eisener, MP |author3=Kosary, CL |title=SEER cancer statistics review, 1975-2001|journal=National Cancer Institute|year=2004}}</ref> Significant progress has been built in the last 25 years as there are now approximately 270,000 survivors of pediatric cancer in the U.S., which translates to approximately 1 in every 640 young adults being a survivor of childhood cancer.<ref>{{cite journal|last=Aziz|first=NM |author2=Oeffinger, KC |author3=Brooks, S |author4=Turoff, AJ.|title=Comprehensive long-term follow-up programs for pediatric cancer survivors|journal=Cancer|year=2009|pages=841–848}}</ref><ref>{{cite book|last=Hewitt|first=M|title=Childhood cancer survivorship: Improving care and quality of life|year=2003|publisher=National Academies Press|location=Washington, D.C.|author2=Weisner, SL |author3=Simone, JV }}</ref> However, as studies have shown, as patient needs increase, the likelihood of having an unmet need also increases.<ref>{{cite journal|last=Heinrich|first=RL|author2=Schag, CC |author3=Ganz, PA |title=Living with cancer. The cancer inventory of problem situations.|journal=Journal of Clinical Psychiatry|year=1984|volume=40|issue=4|pages=972–980|doi=10.1002/1097-4679(198407)40:4<972::aid-jclp2270400417>3.0.co;2-w}}</ref> For the AYA population, 2 out of 3 childhood cancer survivors will develop 1 complication due to the therapy they received and 1 out of 3 will develop serious or life-threatening complications, meaning they will most likely need treatment and follow-up care.<ref>{{cite journal|last=Oeffinger|first=KC|author2=Hudson|title=MM|journal=CA: A Cancer Journal for Clinicians|year=2004|volume=54|issue=4|pages=208–236|doi=10.3322/canjclin.54.4.208}}</ref> In addition, AYAs may experience greater difficulties adhering to treatment, which may negatively impact future outcomes.<ref>{{Cite journal|last=Robertson|first=Eden|last2=Wakefield|first2=Claire|last3=Marshall|first3=Kate|last4=Sansom-Daly|first4=Ursula|date=2015-07-10|title=Strategies to improve adherence to treatment in adolescents and young adults with cancer: a systematic review|journal=Clinical Oncology in Adolescents and Young Adults|language=English|volume= 5|doi=10.2147/coaya.s85988|pages=35}}</ref>


An AYA survivor faces a variety of issues as a result of their cancer diagnosis and treatment that are unique to their particular age group which differentiate their survivor population from the adult survivor population. For example, AYA survivors report that their education, employment, sexual functioning,<ref>{{cite journal|last=Bober|first=Sharon L.|author2=Zhou, Eric S. |author3=Chen, Bing |title=Sexual Function in Childhood Cancer Survivors: A Report from Project REACH|journal=The Journal of Sexual Medicine|date=August 2013|volume=10|issue=8|pages=2084–2093|doi=10.1111/jsm.12193|pmid=23679087|display-authors=etal}}</ref> marriage, fertility, and other life values are impacted by their cancer.<ref>{{cite journal|last=Zebrack|first=BJ|author2=Zeitzer, LK|title=Quality of life issues and cancer survivorship|journal=Current Problems in Cancer|year=2003|volume=27|pages=198–211|doi=10.1016/s0147-0272(03)00027-8}}</ref><ref>{{Cite journal|last=Robertson|first=Eden G.|last2=Sansom-Daly|first2=Ursula M.|last3=Wakefield|first3=Claire E.|last4=Ellis|first4=Sarah J.|last5=McGill|first5=Brittany C.|last6=Doolan|first6=Emma L.|last7=Cohn|first7=Richard J.|date=2016-02-17|title=Sexual and Romantic Relationships: Experiences of Adolescent and Young Adult Cancer Survivors|journal=Journal of Adolescent and Young Adult Oncology|doi=10.1089/jayao.2015.0061|issn=2156-535X|pmid=26885746}}</ref> Data show that AYA survivors have a much greater risk of getting a second primary malignancy as a side effect of the treatment for their original diagnosis. It is believed that AYAs have a much higher relative risk of developing a second primary cancer because the intensity of the treatment for their original diagnosis, typically including any combination of chemotherapy, surgery, and radiation, is much higher than the level of intensity given to patients over 40.<ref name="Soliman 2008">{{cite journal|last=Soliman|first=H|author2=Agresta, SV|title=Current Issues in Adolescent and Young Adult Cancer Survivorship|journal=Cancer Control|date=January 2008|volume=15|issue=1}}</ref> Furthermore, since AYA survivors are diagnosed and treated at such a young age, their length of time as a survivor is much longer than their adult counterparts, making it more likely they will face a second primary cancer in their lifetime.<ref name="Soliman 2008"/>
An AYA survivor faces a variety of issues as a result of their cancer diagnosis and treatment that are unique to their particular age group which differentiate their survivor population from the adult survivor population. For example, AYA survivors report that their education, employment, sexual functioning,<ref>{{cite journal|last=Bober|first=Sharon L.|author2=Zhou, Eric S. |author3=Chen, Bing |title=Sexual Function in Childhood Cancer Survivors: A Report from Project REACH|journal=The Journal of Sexual Medicine|date=August 2013|volume=10|issue=8|pages=2084–2093|doi=10.1111/jsm.12193|pmid=23679087|display-authors=etal}}</ref> marriage, fertility, and other life values are impacted by their cancer.<ref>{{cite journal|last=Zebrack|first=BJ|author2=Zeitzer, LK|title=Quality of life issues and cancer survivorship|journal=Current Problems in Cancer|year=2003|volume=27|issue=4|pages=198–211|doi=10.1016/s0147-0272(03)00027-8|pmid=12855951|citeseerx=10.1.1.170.8566}}</ref><ref>{{Cite journal|last=Robertson|first=Eden G.|last2=Sansom-Daly|first2=Ursula M.|last3=Wakefield|first3=Claire E.|last4=Ellis|first4=Sarah J.|last5=McGill|first5=Brittany C.|last6=Doolan|first6=Emma L.|last7=Cohn|first7=Richard J.|date=2016-02-17|title=Sexual and Romantic Relationships: Experiences of Adolescent and Young Adult Cancer Survivors|journal=Journal of Adolescent and Young Adult Oncology|volume=5|issue=3|pages=286–91|doi=10.1089/jayao.2015.0061|issn=2156-535X|pmid=26885746}}</ref> Data show that AYA survivors have a much greater risk of getting a second primary malignancy as a side effect of the treatment for their original diagnosis. It is believed that AYAs have a much higher relative risk of developing a second primary cancer because the intensity of the treatment for their original diagnosis, typically including any combination of chemotherapy, surgery, and radiation, is much higher than the level of intensity given to patients over 40.<ref name="Soliman 2008">{{cite journal|last=Soliman|first=H|author2=Agresta, SV|title=Current Issues in Adolescent and Young Adult Cancer Survivorship|journal=Cancer Control|date=January 2008|volume=15|issue=1}}</ref> Furthermore, since AYA survivors are diagnosed and treated at such a young age, their length of time as a survivor is much longer than their adult counterparts, making it more likely they will face a second primary cancer in their lifetime.<ref name="Soliman 2008"/>


===Barriers to quality long-term follow-up care===
===Barriers to quality long-term follow-up care===
Childhood cancer survivors, in particular, need comprehensive long-term follow-up care to thrive. One way this can be accomplished is through continuous follow-up care with a primary care physician who is trained to identify possible late effects from previous treatments and therapies.<ref>{{cite journal|last=Bhatia|first=S|author2=Casillas, J |author3=Hudson, MM |author4= Landier, W |title=Long-term Follow-up Care for Pediatric Cancer Survivors|journal=American Academy of Pediatrics|date=March 2009|volume=123|issue=3|pages=906–915 |doi=10.1542/peds.2008-3688}}</ref>
Childhood cancer survivors, in particular, need comprehensive long-term follow-up care to thrive. One way this can be accomplished is through continuous follow-up care with a primary care physician who is trained to identify possible late effects from previous treatments and therapies.<ref>{{cite journal|last=Bhatia|first=S|author2=Casillas, J |author3=Hudson, MM |author4= Landier, W |title=Long-term Follow-up Care for Pediatric Cancer Survivors|journal=American Academy of Pediatrics|date=March 2009|volume=123|issue=3|pages=906–915 |doi=10.1542/peds.2008-3688|pmid=19255020|pmc=2696806}}</ref>


The [[Children's Oncology Group]] (COG) has designed a set of survivorship guidelines that hope to aid both health care professionals and survivors themselves, in both the intricacies and basics of long-term follow-up care. The COG has guidelines for how a patient should put together their own “treatment summary”, so they can have their treatment history with them when they visit any health care provider. The COG suggests that a survivor include the following in his/her treatment summary:
The [[Children's Oncology Group]] (COG) has designed a set of survivorship guidelines that hope to aid both health care professionals and survivors themselves, in both the intricacies and basics of long-term follow-up care. The COG has guidelines for how a patient should put together their own “treatment summary”, so they can have their treatment history with them when they visit any health care provider. The COG suggests that a survivor include the following in his/her treatment summary:
Line 84: Line 84:


== Care ==
== Care ==
Studies among endometrial cancer survivors show that satisfaction with information provided about the disease and treatment increases the quality of life, lowers depression and results in less anxiety.<ref name="Husson">{{cite journal | author = Husson O. ''et al.'' | year = 2011 | title = The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review | journal = Ann Oncol | volume = 22 | issue = | pages = 761–772 | doi=10.1093/annonc/mdq413 | pmid=20870912 | pmc=3065875}}</ref> People who receive information on paper, compared to oral, indicate that they receive more information and are more satisfied about the information provided.<ref name="Nicolaije 2012">{{cite journal | author = Nicolaije K.A. ''et al.'' | year = 2012 | title = Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry | url = | journal = Patient education and counseling | volume = 88 | issue = 3| pages = 427–35 | doi = 10.1016/j.pec.2012.05.002 | pmid = 22658248 }}</ref> The American Institute of Medicine and the [[Dutch Health Council]] recommend the use of a Survivorship Care Plan; which is a summary of a patient's course of treatment, with recommendations for subsequent surveillance, management of late effects, and strategies for health promotion.<ref name="Poll-Franse">{{cite journal | author = Van de Poll-Franse L.V. ''et al.'' | year = 2011 | title = The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. | url = | journal = Trials | volume = 12| page = 256 | doi = 10.1186/1745-6215-12-256 | pmid = 22141750 | pmc=3286432}}</ref>
Studies among endometrial cancer survivors show that satisfaction with information provided about the disease and treatment increases the quality of life, lowers depression and results in less anxiety.<ref name="Husson">{{cite journal | author = Husson O. ''et al.'' | year = 2011 | title = The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review | journal = Ann Oncol | volume = 22 | issue = 4| pages = 761–772 | doi=10.1093/annonc/mdq413 | pmid=20870912 | pmc=3065875}}</ref> People who receive information on paper, compared to oral, indicate that they receive more information and are more satisfied about the information provided.<ref name="Nicolaije 2012">{{cite journal | author = Nicolaije K.A. ''et al.'' | year = 2012 | title = Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry | url = | journal = Patient Education and Counseling | volume = 88 | issue = 3| pages = 427–35 | doi = 10.1016/j.pec.2012.05.002 | pmid = 22658248 }}</ref> The American Institute of Medicine and the [[Dutch Health Council]] recommend the use of a Survivorship Care Plan; which is a summary of a patient's course of treatment, with recommendations for subsequent surveillance, management of late effects, and strategies for health promotion.<ref name="Poll-Franse">{{cite journal | author = Van de Poll-Franse L.V. ''et al.'' | year = 2011 | title = The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. | url = | journal = Trials | volume = 12| page = 256 | doi = 10.1186/1745-6215-12-256 | pmid = 22141750 | pmc=3286432}}</ref>


Cancer survivors are encouraged to meet the same guidelines for physical activity as the rest of the population.<ref>U.S. Department of Health and Human Services. Physical activity guidelines for Americans. 2008. https://health.gov/paguidelines/pdf/paguide.pdf.</ref><ref>Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.</ref> Increased physical activity reduces both all-cause and cancer-specific mortality in breast<ref>Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54.</ref> and colo-rectal cancer survivors.<ref>Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293–311.</ref> Physical activity improves quality of life among a range of cancer survivors<ref>Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566.</ref> and may also assist with cancer-related fatigue and common co-morbidities.<ref>van Roekel EH, Winkler EA, Bours MJ, et al. Associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life in colorectal cancer survivors. Prev Med Rep. 2016;4:262–9.</ref><ref>Phillips SM, Lloyd GR, Awick EA, McAuley E. Correlates of objectively measured sedentary behavior in breast cancer survivors. Cancer Causes Control. 2016;27(6):787–95.</ref>
Cancer survivors are encouraged to meet the same guidelines for physical activity as the rest of the population.<ref>U.S. Department of Health and Human Services. Physical activity guidelines for Americans. 2008. https://health.gov/paguidelines/pdf/paguide.pdf.</ref><ref>Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.</ref> Increased physical activity reduces both all-cause and cancer-specific mortality in breast<ref>Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54.</ref> and colo-rectal cancer survivors.<ref>Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293–311.</ref> Physical activity improves quality of life among a range of cancer survivors<ref>Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566.</ref> and may also assist with cancer-related fatigue and common co-morbidities.<ref>van Roekel EH, Winkler EA, Bours MJ, et al. Associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life in colorectal cancer survivors. Prev Med Rep. 2016;4:262–9.</ref><ref>Phillips SM, Lloyd GR, Awick EA, McAuley E. Correlates of objectively measured sedentary behavior in breast cancer survivors. Cancer Causes Control. 2016;27(6):787–95.</ref>
Line 90: Line 90:
Diet can also impact long-term mortality, with evidence across various cancer types.<ref>Xing MY, Xu SZ, Shen P. Effect of low-fat diet on breast cancer survival: a meta-analysis. Asian Pac J Cancer P. 2014;15(3):1141–4.</ref><ref>Brennan SF, Woodside JV, Lunny PM, Cardwell CR, Cantwell MM. Dietary fat and breast cancer mortality: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2015.</ref><ref>Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298(7):754–64.</ref><ref>Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med. 2015;4(12):1933–47.</ref>
Diet can also impact long-term mortality, with evidence across various cancer types.<ref>Xing MY, Xu SZ, Shen P. Effect of low-fat diet on breast cancer survival: a meta-analysis. Asian Pac J Cancer P. 2014;15(3):1141–4.</ref><ref>Brennan SF, Woodside JV, Lunny PM, Cardwell CR, Cantwell MM. Dietary fat and breast cancer mortality: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2015.</ref><ref>Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298(7):754–64.</ref><ref>Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med. 2015;4(12):1933–47.</ref>


However, adherence to diet and exercise recommendations among cancer survivors is often poor.<ref>Winkels RM, van Lee L, Beijer S, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations in colorectal cancer survivors: results of the PROFILES registry. Cancer Med. 2016</ref><ref>Blanchard CM, Courneya KS, Stein K. American Cancer Society’s SCS, II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(13):2198–204.</ref><ref>Williams K, Steptoe A, Wardle J. Is a cancer diagnosis a trigger for health behaviour change? Findings from a prospective, population-based study. Br J Cancer. 2013;108(11):2407–12.</ref> Digital [[behavior change (individual)|behaviour change]] interventions can be successful at increasing physical activity and may also help with diet in cancer survivors.<ref>{{cite journal|last=Roberts|first=Anna L.|author2=Fisher, A|author3=Smith, L|author4=Heinrich, M|author5=Potts, HWW|title=Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: A systematic review and meta-analysis|journal=Journal of Cancer Survivorship|date=August 2017|doi=10.1007/s11764-017-0632-1}}</ref>
However, adherence to diet and exercise recommendations among cancer survivors is often poor.<ref>Winkels RM, van Lee L, Beijer S, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations in colorectal cancer survivors: results of the PROFILES registry. Cancer Med. 2016</ref><ref>Blanchard CM, Courneya KS, Stein K. American Cancer Society’s SCS, II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(13):2198–204.</ref><ref>Williams K, Steptoe A, Wardle J. Is a cancer diagnosis a trigger for health behaviour change? Findings from a prospective, population-based study. Br J Cancer. 2013;108(11):2407–12.</ref> Digital [[behavior change (individual)|behaviour change]] interventions can be successful at increasing physical activity and may also help with diet in cancer survivors.<ref>{{cite journal|last=Roberts|first=Anna L.|author2=Fisher, A|author3=Smith, L|author4=Heinrich, M|author5=Potts, HWW|title=Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: A systematic review and meta-analysis|journal=Journal of Cancer Survivorship|volume=11|issue=6|pages=704–719|date=August 2017|doi=10.1007/s11764-017-0632-1|pmid=28779220|pmc=5671545}}</ref>


==Family members==
==Family members==
Family members can be significantly affected by the cancer experience of their loved ones.<ref>{{Cite journal|last=Girgis|first=Afaf|last2=Lambert|first2=Sylvie|last3=Johnson|first3=Claire|last4=Waller|first4=Amy|last5=Currow|first5=David|date=2013-07-01|title=Physical, Psychosocial, Relationship, and Economic Burden of Caring for People With Cancer: A Review|url=http://jop.ascopubs.org/content/9/4/197|journal=Journal of Oncology Practice|language=en|volume=9|issue=4|pages=197–202|doi=10.1200/JOP.2012.000690|issn=1554-7477|pmc=3710169|pmid=23942921}}</ref><ref>{{Cite journal|last=Wakefield|first=Claire E.|last2=Drew|first2=Donna|last3=Ellis|first3=Sarah J.|last4=Doolan|first4=Emma L.|last5=McLoone|first5=Jordana K.|last6=Cohn|first6=Richard J.|date=2014-03-01|title='What they're not telling you': a new scale to measure grandparents' information needs when their grandchild has cancer|journal=Patient Education and Counseling|volume=94|issue=3|pages=351–355|doi=10.1016/j.pec.2013.10.030|issn=1873-5134|pmid=24315159}}</ref> For parents of children with cancer, finishing treatment can be a particularly vulnerable time. In the post-treatment period, some parents may experience increases in anxiety, depression and feelings of helplessness.<ref>{{Cite journal|last=Wijnberg-Williams|first=Barbara J.|last2=Kamps|first2=Willem A.|last3=Klip|first3=Ed C.|last4=Hoekstra-Weebers|first4=Josette E. H. M.|date=2006-01-01|title=Psychological adjustment of parents of pediatric cancer patients revisited: five years later|journal=Psycho-Oncology|volume=15|issue=1|pages=1–8|doi=10.1002/pon.927|issn=1057-9249|pmid=15880477}}</ref> Evidence-based psychological interventions tailored to the needs of parents of childhood cancer survivors may assist parents in resuming their normal lives after their child has finished treatment.<ref>{{Cite journal|last=Wakefield|first=Claire E|last2=Sansom-Daly|first2=Ursula M|last3=McGill|first3=Brittany C|last4=McCarthy|first4=Maria|last5=Girgis|first5=Afaf|last6=Grootenhuis|first6=Martha|last7=Barton|first7=Belinda|last8=Patterson|first8=Pandora|last9=Osborn|first9=Michael|date=2015-04-11|title=Online parent-targeted cognitive-behavioural therapy intervention to improve quality of life in families of young cancer survivors: study protocol for a randomised controlled trial|url=https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0681-6|journal=Trials|language=En|volume=16|issue=1|doi=10.1186/s13063-015-0681-6|issn=1745-6215|pmc=4395969|pmid=25872773}}</ref>
Family members can be significantly affected by the cancer experience of their loved ones.<ref>{{Cite journal|last=Girgis|first=Afaf|last2=Lambert|first2=Sylvie|last3=Johnson|first3=Claire|last4=Waller|first4=Amy|last5=Currow|first5=David|date=2013-07-01|title=Physical, Psychosocial, Relationship, and Economic Burden of Caring for People With Cancer: A Review|url=http://jop.ascopubs.org/content/9/4/197|journal=Journal of Oncology Practice|language=en|volume=9|issue=4|pages=197–202|doi=10.1200/JOP.2012.000690|issn=1554-7477|pmc=3710169|pmid=23942921}}</ref><ref>{{Cite journal|last=Wakefield|first=Claire E.|last2=Drew|first2=Donna|last3=Ellis|first3=Sarah J.|last4=Doolan|first4=Emma L.|last5=McLoone|first5=Jordana K.|last6=Cohn|first6=Richard J.|date=2014-03-01|title='What they're not telling you': a new scale to measure grandparents' information needs when their grandchild has cancer|journal=Patient Education and Counseling|volume=94|issue=3|pages=351–355|doi=10.1016/j.pec.2013.10.030|issn=1873-5134|pmid=24315159}}</ref> For parents of children with cancer, finishing treatment can be a particularly vulnerable time. In the post-treatment period, some parents may experience increases in anxiety, depression and feelings of helplessness.<ref>{{Cite journal|last=Wijnberg-Williams|first=Barbara J.|last2=Kamps|first2=Willem A.|last3=Klip|first3=Ed C.|last4=Hoekstra-Weebers|first4=Josette E. H. M.|date=2006-01-01|title=Psychological adjustment of parents of pediatric cancer patients revisited: five years later|journal=Psycho-Oncology|volume=15|issue=1|pages=1–8|doi=10.1002/pon.927|issn=1057-9249|pmid=15880477|url=https://www.rug.nl/research/portal/en/publications/psychological-adjustment-of-parents-of-pediatric-cancer-patients-revisited(e9249a8a-c4e9-478d-92e5-909bc886356e).html|type=Submitted manuscript}}</ref> Evidence-based psychological interventions tailored to the needs of parents of childhood cancer survivors may assist parents in resuming their normal lives after their child has finished treatment.<ref>{{Cite journal|last=Wakefield|first=Claire E|last2=Sansom-Daly|first2=Ursula M|last3=McGill|first3=Brittany C|last4=McCarthy|first4=Maria|last5=Girgis|first5=Afaf|last6=Grootenhuis|first6=Martha|last7=Barton|first7=Belinda|last8=Patterson|first8=Pandora|last9=Osborn|first9=Michael|date=2015-04-11|title=Online parent-targeted cognitive-behavioural therapy intervention to improve quality of life in families of young cancer survivors: study protocol for a randomised controlled trial|journal=Trials|language=En|volume=16|issue=1|pages=153|doi=10.1186/s13063-015-0681-6|issn=1745-6215|pmc=4395969|pmid=25872773}}</ref>


Spouses of cancer survivors are more likely than other people to experience anxiety in the years after their partner's successful treatment.<ref name="pmid23759376">{{cite journal
Spouses of cancer survivors are more likely than other people to experience anxiety in the years after their partner's successful treatment.<ref name="pmid23759376">{{cite journal
Line 126: Line 126:
|location=USA
|location=USA
|year=2010
|year=2010
|isbn=0-19-974045-3
|isbn=978-0-19-974045-1
|oclc= 535493589 }}</ref>
|oclc= 535493589 }}</ref>
<ref name=Hart>{{cite journal
<ref name=Hart>{{cite journal
Line 134: Line 134:
|date=August 2007
|date=August 2007
| doi = 10.1089/act.2007.13406
| doi = 10.1089/act.2007.13406
| pmid = 17388756
| volume = 13
| volume = 13
| issue = 4
| issue = 4
| pages = 183–186
| pages = 183–186
}}</ref>
| url = http://www.liebertonline.com/doi/abs/10.1089/act.2007.13406?cookieSet=1&journalCode=act }}</ref>
<ref name=depression>{{cite news
<ref name=depression>{{cite news
| title=Remy’s woes befall many after cancer: Depression can hit as survivors adjust
| title=Remy’s woes befall many after cancer: Depression can hit as survivors adjust

Revision as of 14:20, 31 October 2018

A cancer survivor is a person with cancer of any type who is still living. Whether a person becomes a survivor at the time of diagnosis or after completing treatment, whether people who are actively dying are considered survivors, and whether healthy friends and family members of the cancer patient are also considered survivors, varies from group to group. Some people who have been diagnosed with cancer reject the term survivor or disagree with some definitions of it.

How many people are cancer survivors depends on the definition used. Currently nearly 65% of adults diagnosed with cancer in the developed world are expected to live at least five years after the cancer is discovered.[1] In the U.S. for example, about 11 million Americans alive today—one in 30 people–are either currently undergoing treatment for cancer or have done so in the past.[2]

Many cancer survivors describe the process of living with and beating cancer as a life-changing experience.[3] It is not uncommon for survivors to use the experience as opportunities for creative self-transformation into a "better person" or as motivation to meet goals of great personal importance, such as climbing a mountain or reconciling with an estranged family member. This process of posttraumatic growth is called benefit finding.[4] Cancer survivors often have specific medical and non-medical needs related to their cancer experience.

Definitions and alternatives

Macmillan Cancer Support in the UK defines a cancer survivor as someone who is "living with or beyond cancer", namely someone who:

  • has completed initial cancer management and has no apparent evidence of active disease;
  • is living with progressive disease and may be receiving cancer treatment, but is not in the terminal phases of illness; or
  • has had cancer in the past.[5]

The National Coalition for Cancer Survivorship (NCCS) pioneered the definition of survivor as being any person diagnosed with cancer, from the time of initial diagnosis until his or her death. This expansive definition of "survivor" includes people who are dying from untreatable cancer. NCCS later expanded the definition of survivor even further to include family, friends and voluntary caregivers who are affected by the diagnosis in any way.[6] The US National Cancer Institute's Office of Cancer Survivorship uses a variant of this expanded definition.[6]

The word survivor is a loaded term.[3] Within the breast cancer culture, survivorship is conferred upon women (and men) who are perceived as having suffered emotional or physical trauma, even if their breast cancer was a non-life-threatening pre-cancerous condition like LCIS or DCIS. The term tends to erase and degrade people who are dying of incurable cancer. This idea of survivorship emphasizes and values longevity of life after diagnosis, while overlooking issues of quality of life.[3]

Some people reject the term survivor as being a narrow conceptualization of highly variable human experiences. Alternatives include alivers and thrivers, which put emphasis on living as well as possible, despite limitations and disability.[3] A third term, the diers, is used by some terminally ill patients who reject the claim that dying is part of survivorship or should be covered up with inappropriately optimistic language.[3]

The term previvor has been used to describe unaffected carriers. Unaffected carriers, or previvors, are those who have not diagnosed with cancer, but who know that they are likely to develop cancer due to certain genetic mutations that form a known cancer syndrome. They have a survived the predisposition, or higher risk, of cancer.[7][8] As such, this is the first generation in human history who, armed with information about a predisposition to a cancer after opting into DNA testing, can make informed choices prior to cancer diagnosis. The typical previvor has tested positive for a BRCA mutation and learned that she is at high risk for developing breast cancer and ovarian cancer, and is attempting to manage that risk through a combination of increased surveillance through mammograms, breast MRIs, pelvic ultrasounds, oophorectomy, bilateral mastectomy, and other medical procedures. There has been much controversy over the term previvor, due to the fact that the name compares these healthy women to people have actually been diagnosed with invasive cancer.

Needs of cancer survivors

People who have finished cancer treatment often have psychological and physical medical challenges.[9] These effects can vary from person to person, change over time, and range in intensity from mild and intermittent to fully disabling. They commonly include fatigue,[10] pain,[11] sleep problems,[12] physical side effects like lymphoedema,[13] weight gain,[14] anxiety and depression,[15] fear of cancer recurrence,[16] and impaired quality of life.[17]

Psychosocial

Returning to life

If the treatment is lengthy and disruptive, many patients experience some difficulty in returning to normal daily life.[18] The energy needed to cope with a rigorous treatment program may have caused them to disconnect from previous daily patterns, such as working, normal self-care, and housekeeping. A small number of patients become dependent on the attention and sympathy that they received during their treatment and feel neglected when life returns to normal. There are tremendous implications that cancer has on the relationships that survivors have with their loved ones (particularly their partners) once their cancer has been treated,[19] and social support plays a critical role in their long-term emotional adjustment.[20]

Ongoing effects

Some survivors, even if the cancer has been permanently cured, struggle emotionally from the trauma of having experienced a life-threatening disease.[21] Cancer survivors suffer from more psychological distress than those who have never experienced cancer (5.6% compared to 3.0%)[22] Serious psychosocial distress was seen 40% more among cancer survivors of five years or more than in those who have never had cancer.[22] About 10% develop major depressive disorder; others experience an adjustment disorder.[21] In young adult cancer survivors, one small study found that 20% of participants met the full clinical diagnosis of post-traumatic stress disorder (PTSD), and 45% to 95% displayed at least one symptom of PTSD.[23] Survivors of adult cancer are at an increased risk of suicidal ideology (having thoughts about suicide),[24] while as many as 13% of childhood cancer survivors experience suicidal ideology.[25] Issues of pain and physical ailments have been hypothesized as major contributing factors in cancer survivors experiencing this suicidal ideology.

Fear of cancer recurrence

Patients whose cancer is in remission may still have to cope with the uncertainty that at any time their cancer could return without warning. After the initial treatment has ended, anxiety is more common among cancer survivors than among other people.[26] This anxiety regarding the cancer's return is referred to as fear of cancer recurrence.[27] Many patients are anxious that any minor symptom indicates that the cancer has returned, with as many as 9 in 10 patients fearful that their cancer will recur or spread.[2] In addition to the appearance of any new aches and pains, common triggers for a fear that the cancer may return include hearing that someone else has been diagnosed with cancer, annual medical exams to determine whether the cancer recurred and news stories about cancer.[28] This anxiety leads to more medical check ups, which can be measured even after a period of up to ten years.[29] This fear can have a significant impact on individual's lives, resulting in difficulties in their daily life such as work and socialising, and difficulties planning for the future.[30] Overall, fear of cancer recurrence is related to a reduced quality of life in cancer survivors[30]

While Fear of Cancer Recurrence (FCR) can be adaptive at low levels, high levels of FCR require psychological treatment. At present, there are no psychometrically sound measures of FCR, which makes research into the effectiveness of treatment protocols difficult to interpret.[31] Treatments that are being investigated include: cognitive-behavioural therapy,[32] Meta-cognitive therapy[33] and Cognitive-existential group therapy[34] and exercise.[35]

Survivorship

The cultural ideal of a survivor may add to individual patients' distress if the patient is unable or unwilling to live up to the ideal.[3] The ideal survivor is bravely committed to mainstream medicine and optimistic or even certain of a physical cure. He or she is open about diagnosis and treatment and becomes an educated, empowered medical consumer. The ideal survivor, like a superwoman who simultaneously manages her home, family, and career, struggles valiantly to prevent cancer from affecting loved ones by appearing, behaving, and working as much as possible. Once the immediate crisis is past, the person may feel strongly pressured to donate time, money, and energy to cancer-related organizations. Above all, the ideal survivor does not die of cancer. People who publicly conform to this ideal are given social status and respect.[3]

Physical

In terms of medical challenges, some survivors experience cancer-related fatigue, may have long-term side effects from cancer and its treatment, and may need extensive rehabilitation for mobility and function if aggressive surgery was required to remove the cancer. They may experience temporary or persistent post-chemotherapy cognitive impairment. Some young survivors lose their ability to have children.

Cancer survivors frequently need medical monitoring, and some treatments for unrelated diseases in the future may be contraindicated. For example, a patient who has had a significant amount of radiation therapy may not be a good candidate for more radiation treatments in the future. To assist with these needs, "survivor care plans" have been promoted. These are personalized documents that describe the person's diagnosis and treatment in detail, list common known side effects, and specifically outline the steps that the survivor should take in the future, ranging from maintaining a healthy weight to receiving specific medical tests on a stated schedule.[36]

Medical tests to determine whether the cancer has returned commonly provoke fears. Informally, this is called scanxiety, a portmanteau of scan and anxiety. A desire to avoid feeling this fear can prompt survivors to postpone or refuse tests.[37][38]

Survivors of childhood cancer have a life expectancy up to 28% shorter than people in the general population.[39] Therefore, there is a need to closely monitor these patients for much longer than usual. The Children's Oncology Group recommends that monitoring should include periodic follow up and screening by a clinician familiar with these patients' risks. Improving these patients' longevity requires recognition and treatment of illnesses associated with late effects in the decades after therapy for childhood cancer. For example, survivors of childhood cancer may have more difficulty than typical with breastfeeding and require more support to undertake this health-promoting activity.[40] Others experience various forms of heart disease. One challenge to achieving this goal is that childhood cancer survivors are both very adaptable and accustomed to denying difficulties; as a result, they tend to minimize their symptoms. Therefore, internists may not give them all the attention they need and thus the actual help they may need. Symptom management, health promotion, specific attention to psychosocial needs, and surveillance for recurrence and specific late effects of treatment are helpful.[39]

Adolescent and young adult survivors

Adolescent and young adult (AYA) survivors, often defined as being between the ages of 15 and 39, have seen advancements in technology and modern medicine causing a dramatic increase in the number of AYA survivors. Prior to 1970, being diagnosed with cancer during childhood was considered a universally fatal disease. From 1995 to 2000, however, the 5-year survival rate for children diagnosed with cancer was 80%.[41] Significant progress has been built in the last 25 years as there are now approximately 270,000 survivors of pediatric cancer in the U.S., which translates to approximately 1 in every 640 young adults being a survivor of childhood cancer.[42][43] However, as studies have shown, as patient needs increase, the likelihood of having an unmet need also increases.[44] For the AYA population, 2 out of 3 childhood cancer survivors will develop 1 complication due to the therapy they received and 1 out of 3 will develop serious or life-threatening complications, meaning they will most likely need treatment and follow-up care.[45] In addition, AYAs may experience greater difficulties adhering to treatment, which may negatively impact future outcomes.[46]

An AYA survivor faces a variety of issues as a result of their cancer diagnosis and treatment that are unique to their particular age group which differentiate their survivor population from the adult survivor population. For example, AYA survivors report that their education, employment, sexual functioning,[47] marriage, fertility, and other life values are impacted by their cancer.[48][49] Data show that AYA survivors have a much greater risk of getting a second primary malignancy as a side effect of the treatment for their original diagnosis. It is believed that AYAs have a much higher relative risk of developing a second primary cancer because the intensity of the treatment for their original diagnosis, typically including any combination of chemotherapy, surgery, and radiation, is much higher than the level of intensity given to patients over 40.[50] Furthermore, since AYA survivors are diagnosed and treated at such a young age, their length of time as a survivor is much longer than their adult counterparts, making it more likely they will face a second primary cancer in their lifetime.[50]

Barriers to quality long-term follow-up care

Childhood cancer survivors, in particular, need comprehensive long-term follow-up care to thrive. One way this can be accomplished is through continuous follow-up care with a primary care physician who is trained to identify possible late effects from previous treatments and therapies.[51]

The Children's Oncology Group (COG) has designed a set of survivorship guidelines that hope to aid both health care professionals and survivors themselves, in both the intricacies and basics of long-term follow-up care. The COG has guidelines for how a patient should put together their own “treatment summary”, so they can have their treatment history with them when they visit any health care provider. The COG suggests that a survivor include the following in his/her treatment summary:

  • Name of disease, date of diagnosis, stage of disease, contact information of the clinics/hospitals where you received your care
  • Names and doses of the chemotherapy and radiation you have received and the area of the body that was radiated
  • Names and dates of any surgeries you have had
  • If you have received a transplant, the type of transplant and where it was received and whether you developed any chronic Graft-versus-Host Disease
  • Names and dates of any significant complications and treatment received for those complications[52]

With the treatment summary, experts hope that survivors will be better equipped to face the significant burden of maintaining quality follow-up care long after their original treatment. This is especially important for the AYA population, in particular, because they are typically facing major social changes regarding their relationship status, employment or education status, their insurance coverage, and even their place of residence, etc. Typically, most of these factors are pretty constant for the adult population and if they experience any changes, it would occur in one or two aspects of their life. However, with the AYA population, the period of time until they are 40 is when they are going to, for the majority of the population, undergo the most change. This reality underscores the importance of a smooth transition from child-centered to adult-focused health care services through which they are consistently managed.[53]

Impact of Affordable Care Act on the AYA survivor population

The US Affordable Care Act (ACA) in 2010 makes it illegal for health insurance providers to deny coverage for a pre-existing condition, such as previously having survived cancer.[54] Young adults will now be required to have insurance coverage and, with a few exceptions, will be able to be covered under their parent's coverage until the age of 26 as a dependent in their parent's plan.[54]

Care

Studies among endometrial cancer survivors show that satisfaction with information provided about the disease and treatment increases the quality of life, lowers depression and results in less anxiety.[55] People who receive information on paper, compared to oral, indicate that they receive more information and are more satisfied about the information provided.[56] The American Institute of Medicine and the Dutch Health Council recommend the use of a Survivorship Care Plan; which is a summary of a patient's course of treatment, with recommendations for subsequent surveillance, management of late effects, and strategies for health promotion.[57]

Cancer survivors are encouraged to meet the same guidelines for physical activity as the rest of the population.[58][59] Increased physical activity reduces both all-cause and cancer-specific mortality in breast[60] and colo-rectal cancer survivors.[61] Physical activity improves quality of life among a range of cancer survivors[62] and may also assist with cancer-related fatigue and common co-morbidities.[63][64]

Diet can also impact long-term mortality, with evidence across various cancer types.[65][66][67][68]

However, adherence to diet and exercise recommendations among cancer survivors is often poor.[69][70][71] Digital behaviour change interventions can be successful at increasing physical activity and may also help with diet in cancer survivors.[72]

Family members

Family members can be significantly affected by the cancer experience of their loved ones.[73][74] For parents of children with cancer, finishing treatment can be a particularly vulnerable time. In the post-treatment period, some parents may experience increases in anxiety, depression and feelings of helplessness.[75] Evidence-based psychological interventions tailored to the needs of parents of childhood cancer survivors may assist parents in resuming their normal lives after their child has finished treatment.[76]

Spouses of cancer survivors are more likely than other people to experience anxiety in the years after their partner's successful treatment.[26]

Notable cancer survivors

See Category:Cancer survivors

See also

References

  1. ^ Hart, Jane (August 2007). "Addressing the Psychosocial Needs of Cancer Survivors". Alternative and Complementary Therapies. 13 (4): 183–186. doi:10.1089/act.2007.13406. PMID 17388756.
  2. ^ a b "Cancer survivors face psychological challenges". Sun-Sentinel. Fort Lauderdale, Florida. 22 January 2009.
  3. ^ a b c d e f g Gayle A. Sulik (2010). Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health. USA: Oxford University Press. ISBN 978-0-19-974045-1. OCLC 535493589.
  4. ^ Carr, Brian I. and Jennifer Steel, ed. (2013). Psychological aspects of cancer a guide to emotion and psychological consequences of cancer, their causes and their management. New York: Springer. p. 167. ISBN 9781461448662.
  5. ^ "Living with or beyond cancer". Macmillan Cancer Support. Archived from the original on 16 July 2011. Retrieved 30 November 2010. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  6. ^ a b "DCCPS: OCS: About Cancer Survivorship Research: Survivorship Definitions". Office of Cancer Survivorship of the US National Cancer Institute. 6 November 2006. Archived from the original on 2 January 2011. Retrieved 30 November 2010. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  7. ^ Amy Harmon (16 September 2007). "The DNA Age, Cancer Free at Age 33, but Weighing a Mastectomy". The New York Times. Retrieved 16 September 2007.
  8. ^ "FORCE | Special Populations : Cancer Previvors".
  9. ^ "Living with cancer". Macmillan Cancer Support. Archived from the original on 19 April 2010. Retrieved 30 November 2010. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  10. ^ Weis J. Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):441–6.
  11. ^ van den Beuken-van Everdingen MH, De Rijke JM, Kessel AG, Schouten HC, Van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–49.
  12. ^ Sharma N, Hansen CH, O'Connor M, et al. Sleep problems in cancer patients: prevalence and association with distress and pain. Psycho-Oncology. 2012;21(9):1003–9.
  13. ^ Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536–42.
  14. ^ Koo HY, Seo YG, Cho MH, Kim MJ, Choi HC. Weight change and associated factors in long-term breast cancer survivors. PLoS One. 2016;11(7):e0159098.
  15. ^ Krebber AMH, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology. 2014;23(2):121–30.
  16. ^ Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.
  17. ^ Quinten C, Coens C, Ghislain I, et al. The effects of age on health-related quality of life in cancer populations: a pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. Eur J Cancer. 2015;51(18):2808–19.
  18. ^ Jennings, Dana (29 June 2009). "Losing a Comforting Ritual: Treatment". The New York Times.
  19. ^ Zhou, Eric S.; Kim, Youngmee; Rasheed, Mikal; et al. (December 2011). "Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health". Psychooncology. 20 (12): 1353–1357. doi:10.1002/pon.1855. PMC 3020233. PMID 20925137.
  20. ^ Zhou, Eric S.; Penedo, Frank J.; Bustillo, Natalie E.; et al. (2010). "Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer". Journal of Supportive Oncology. 8 (5): 196–201. doi:10.1016/j.suponc.2010.09.004. PMC 3066633. PMID 21086876.
  21. ^ a b Smith, Stephen (14 August 2009). "Remy's woes befall many after cancer: Depression can hit as survivors adjust". Boston Globe.
  22. ^ a b Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK (July 2009). "Psychological distress in long-term survivors of adult-onset cancer: results from a national survey". Arch. Intern. Med. 169 (14): 1274–81. doi:10.1001/archinternmed.2009.179. PMID 19636028. {{cite journal}}: Unknown parameter |laysummary= ignored (help)
  23. ^ Twombly R (February 2001). "Post-traumatic stress disorder in childhood cancer survivors: how common is it?". J. Natl. Cancer Inst. 93 (4): 262–3. doi:10.1093/jnci/93.4.262. PMID 11181770.
  24. ^ Recklitis CJ, Diller LR, Li X, Najita J, Robison LL, Zeltzer L (February 2010). "Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study". J. Clin. Oncol. 28 (4): 655–61. doi:10.1200/JCO.2009.22.8635. PMC 2816000. PMID 19841325.
  25. ^ Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR (August 2006). "Suicidal ideation and attempts in adult survivors of childhood cancer". J. Clin. Oncol. 24 (24): 3852–7. doi:10.1200/JCO.2006.06.5409. PMID 16921037. {{cite journal}}: Unknown parameter |laysummary= ignored (help)
  26. ^ a b Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (July 2013). "Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis". The Lancet Oncology. 14 (8): 721–32. doi:10.1016/S1470-2045(13)70244-4. PMID 23759376. {{cite journal}}: Unknown parameter |laydate= ignored (help); Unknown parameter |laysource= ignored (help); Unknown parameter |layurl= ignored (help)
  27. ^ Thewes, B.; Lebel, S.; Leclair, C. Seguin; Butow, P. (1 May 2016). "A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors". Supportive Care in Cancer. 24 (5): 2269–2276. doi:10.1007/s00520-015-3025-x. ISSN 0941-4355. PMC 4805701. PMID 26581900.
  28. ^ Gill KM, Mishel M, Belyea M, et al. (May 2004). "Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors". Oncol Nurs Forum. 31 (3): 633–9. doi:10.1188/04.ONF.633-639. PMID 15146229.
  29. ^ Nicolaije K.A.; et al. (May 2013). "Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: A study from the population-based PROFILES registry". Gynecologic Oncology. 129 (2): 324–331. doi:10.1016/j.ygyno.2013.02.018. PMID 23435365. {{cite journal}}: Explicit use of et al. in: |author= (help)
  30. ^ a b Custers, José A. E.; Tielen, Ronald; Prins, Judith B.; Wilt, Johannes H. W. de; Gielissen, Marieke F. M.; Graaf, Winette T. A. van der (14 September 2015). "Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?". Acta Oncologica. 54 (8): 1202–1208. doi:10.3109/0284186X.2014.1003960. ISSN 0284-186X. PMID 25734906.
  31. ^ Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, (2012). "Fear of cancer recurrence: a systematic literature review of self‐report measure". Psycho‐Oncology. 21 (6): 571–587. doi:10.1002/pon.2070. PMID 22021099.{{cite journal}}: CS1 maint: extra punctuation (link) CS1 maint: multiple names: authors list (link)
  32. ^ van de Wal, M. A., Gielissen, M. F., Servaes, P., Knoop, H., Speckens, A. E., & Prins, J. B. (2015). "Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence". BMC Psychology. 3 (1): 12. doi:10.1186/s40359-015-0068-1. PMC 4431367. PMID 25977758.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  33. ^ Butow, P. N., Bell, M. L., Smith, A. B., Fardell, J. E., Thewes, B., Turner, J., ... & Shih, S. (2013). "Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence". BMC Cancer. 13 (1): 201. doi:10.1186/1471-2407-13-201. PMC 3652728. PMID 23617696.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  34. ^ Maheu, C., Lebel, S., Courbasson, C., Lefebvre, M., Singh, M., Bernstein, L. J., ... & Ramanakumar, A. V. (2016). "Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer". BMC Cancer. 16 (1): 291. doi:10.1186/s12885-016-2326-x. PMC 4845394. PMID 27112319.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  35. ^ Brown, Justin C.; Damjanov, Nevena; Courneya, Kerry S.; Troxel, Andrea B.; Zemel, Babette S.; Rickels, Michael R.; Ky, Bonnie; Rhim, Andrew D.; Rustgi, Anil K. (2018). "A Randomized Dose-Response Trial of Aerobic Exercise and Health-Related Quality of Life in Colon Cancer Survivors". Psycho-Oncology. 27 (4): 1221–1228. doi:10.1002/pon.4655. ISSN 1099-1611. PMC 5895514. PMID 29388275.
  36. ^ Neergaard, Lauran (23 October 2007). "'Survivor plans' a long-term cancer-treatment strategy". Associated Press.
  37. ^ McCoyd, Judith L. M.; Kerson, Toba Schwaber (2 March 2016). "Chapter 9". Social Work in Health Settings: Practice in Context. Routledge. ISBN 9781317409113.
  38. ^ Feiler, Bruce (13 June 2011). "Scanxiety. Fear of a postcancer ritual". Time. 177 (24): 56. ISSN 0040-781X. PMID 21682131.
  39. ^ a b Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L (April 2010). "A model-based estimate of cumulative excess mortality in survivors of childhood cancer". Ann. Intern. Med. 152 (7): 409–17, W131–8. doi:10.7326/0003-4819-152-7-201004060-00005. PMC 3086591. PMID 20368646. {{cite journal}}: Unknown parameter |laydate= ignored (help); Unknown parameter |laysource= ignored (help); Unknown parameter |laysummary= ignored (help)
  40. ^ Ogg SW, Hudson MM, Randolph ME, Klosky JL (June 2011). "Protective effects of breastfeeding for mothers surviving childhood cancer". J Cancer Surviv. 5 (2): 175–81. doi:10.1007/s11764-010-0169-z. PMID 21253880.
  41. ^ Ries, LA; Eisener, MP; Kosary, CL (2004). "SEER cancer statistics review, 1975-2001". National Cancer Institute.
  42. ^ Aziz, NM; Oeffinger, KC; Brooks, S; Turoff, AJ. (2009). "Comprehensive long-term follow-up programs for pediatric cancer survivors". Cancer: 841–848.
  43. ^ Hewitt, M; Weisner, SL; Simone, JV (2003). Childhood cancer survivorship: Improving care and quality of life. Washington, D.C.: National Academies Press.
  44. ^ Heinrich, RL; Schag, CC; Ganz, PA (1984). "Living with cancer. The cancer inventory of problem situations". Journal of Clinical Psychiatry. 40 (4): 972–980. doi:10.1002/1097-4679(198407)40:4<972::aid-jclp2270400417>3.0.co;2-w.
  45. ^ Oeffinger, KC; Hudson (2004). "MM". CA: A Cancer Journal for Clinicians. 54 (4): 208–236. doi:10.3322/canjclin.54.4.208.
  46. ^ Robertson, Eden; Wakefield, Claire; Marshall, Kate; Sansom-Daly, Ursula (10 July 2015). "Strategies to improve adherence to treatment in adolescents and young adults with cancer: a systematic review". Clinical Oncology in Adolescents and Young Adults. 5: 35. doi:10.2147/coaya.s85988.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  47. ^ Bober, Sharon L.; Zhou, Eric S.; Chen, Bing; et al. (August 2013). "Sexual Function in Childhood Cancer Survivors: A Report from Project REACH". The Journal of Sexual Medicine. 10 (8): 2084–2093. doi:10.1111/jsm.12193. PMID 23679087.
  48. ^ Zebrack, BJ; Zeitzer, LK (2003). "Quality of life issues and cancer survivorship". Current Problems in Cancer. 27 (4): 198–211. CiteSeerX 10.1.1.170.8566. doi:10.1016/s0147-0272(03)00027-8. PMID 12855951.
  49. ^ Robertson, Eden G.; Sansom-Daly, Ursula M.; Wakefield, Claire E.; Ellis, Sarah J.; McGill, Brittany C.; Doolan, Emma L.; Cohn, Richard J. (17 February 2016). "Sexual and Romantic Relationships: Experiences of Adolescent and Young Adult Cancer Survivors". Journal of Adolescent and Young Adult Oncology. 5 (3): 286–91. doi:10.1089/jayao.2015.0061. ISSN 2156-535X. PMID 26885746.
  50. ^ a b Soliman, H; Agresta, SV (January 2008). "Current Issues in Adolescent and Young Adult Cancer Survivorship". Cancer Control. 15 (1).
  51. ^ Bhatia, S; Casillas, J; Hudson, MM; Landier, W (March 2009). "Long-term Follow-up Care for Pediatric Cancer Survivors". American Academy of Pediatrics. 123 (3): 906–915. doi:10.1542/peds.2008-3688. PMC 2696806. PMID 19255020.
  52. ^ "Introduction to Long-term Follow-Up after Treatment for Childhood, Adolescent, or Young Adult Cancer" (PDF). Children's Oncology Group. 2008. Retrieved 1 February 2012.
  53. ^ Freyer, DR (November 2010). "Transition of Care for Young Adult Survivors of Childhood and Adolescent Cancer: Rationale and Approaches". Journal of Clinical Oncology. 28 (32): 4810–4818. doi:10.1200/jco.2009.23.4278. PMC 3018346. PMID 20351333.
  54. ^ a b "Summary of New Health Reform Law" (PDF). Kaiser Family Foundation. Retrieved 2 February 2012.
  55. ^ Husson O.; et al. (2011). "The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review". Ann Oncol. 22 (4): 761–772. doi:10.1093/annonc/mdq413. PMC 3065875. PMID 20870912. {{cite journal}}: Explicit use of et al. in: |author= (help)
  56. ^ Nicolaije K.A.; et al. (2012). "Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry". Patient Education and Counseling. 88 (3): 427–35. doi:10.1016/j.pec.2012.05.002. PMID 22658248. {{cite journal}}: Explicit use of et al. in: |author= (help)
  57. ^ Van de Poll-Franse L.V.; et al. (2011). "The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial". Trials. 12: 256. doi:10.1186/1745-6215-12-256. PMC 3286432. PMID 22141750. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: unflagged free DOI (link)
  58. ^ U.S. Department of Health and Human Services. Physical activity guidelines for Americans. 2008. https://health.gov/paguidelines/pdf/paguide.pdf.
  59. ^ Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.
  60. ^ Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54.
  61. ^ Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293–311.
  62. ^ Mishra SI, Scherer RW, Geigle PM, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566.
  63. ^ van Roekel EH, Winkler EA, Bours MJ, et al. Associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life in colorectal cancer survivors. Prev Med Rep. 2016;4:262–9.
  64. ^ Phillips SM, Lloyd GR, Awick EA, McAuley E. Correlates of objectively measured sedentary behavior in breast cancer survivors. Cancer Causes Control. 2016;27(6):787–95.
  65. ^ Xing MY, Xu SZ, Shen P. Effect of low-fat diet on breast cancer survival: a meta-analysis. Asian Pac J Cancer P. 2014;15(3):1141–4.
  66. ^ Brennan SF, Woodside JV, Lunny PM, Cardwell CR, Cantwell MM. Dietary fat and breast cancer mortality: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2015.
  67. ^ Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298(7):754–64.
  68. ^ Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies. Cancer Med. 2015;4(12):1933–47.
  69. ^ Winkels RM, van Lee L, Beijer S, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research lifestyle recommendations in colorectal cancer survivors: results of the PROFILES registry. Cancer Med. 2016
  70. ^ Blanchard CM, Courneya KS, Stein K. American Cancer Society’s SCS, II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(13):2198–204.
  71. ^ Williams K, Steptoe A, Wardle J. Is a cancer diagnosis a trigger for health behaviour change? Findings from a prospective, population-based study. Br J Cancer. 2013;108(11):2407–12.
  72. ^ Roberts, Anna L.; Fisher, A; Smith, L; Heinrich, M; Potts, HWW (August 2017). "Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: A systematic review and meta-analysis". Journal of Cancer Survivorship. 11 (6): 704–719. doi:10.1007/s11764-017-0632-1. PMC 5671545. PMID 28779220.
  73. ^ Girgis, Afaf; Lambert, Sylvie; Johnson, Claire; Waller, Amy; Currow, David (1 July 2013). "Physical, Psychosocial, Relationship, and Economic Burden of Caring for People With Cancer: A Review". Journal of Oncology Practice. 9 (4): 197–202. doi:10.1200/JOP.2012.000690. ISSN 1554-7477. PMC 3710169. PMID 23942921.
  74. ^ Wakefield, Claire E.; Drew, Donna; Ellis, Sarah J.; Doolan, Emma L.; McLoone, Jordana K.; Cohn, Richard J. (1 March 2014). "'What they're not telling you': a new scale to measure grandparents' information needs when their grandchild has cancer". Patient Education and Counseling. 94 (3): 351–355. doi:10.1016/j.pec.2013.10.030. ISSN 1873-5134. PMID 24315159.
  75. ^ Wijnberg-Williams, Barbara J.; Kamps, Willem A.; Klip, Ed C.; Hoekstra-Weebers, Josette E. H. M. (1 January 2006). "Psychological adjustment of parents of pediatric cancer patients revisited: five years later". Psycho-Oncology (Submitted manuscript). 15 (1): 1–8. doi:10.1002/pon.927. ISSN 1057-9249. PMID 15880477.
  76. ^ Wakefield, Claire E; Sansom-Daly, Ursula M; McGill, Brittany C; McCarthy, Maria; Girgis, Afaf; Grootenhuis, Martha; Barton, Belinda; Patterson, Pandora; Osborn, Michael (11 April 2015). "Online parent-targeted cognitive-behavioural therapy intervention to improve quality of life in families of young cancer survivors: study protocol for a randomised controlled trial". Trials. 16 (1): 153. doi:10.1186/s13063-015-0681-6. ISSN 1745-6215. PMC 4395969. PMID 25872773.{{cite journal}}: CS1 maint: unflagged free DOI (link)

External links